Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS2 | P35228 | 2/20 | 0.60 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.42 |
| ▸ | FADS1 | O60427 | 1/20 | 0.42 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10748798 | 0.98 | NOS2 (0.59) | NOS2HTTRECQLALOX15HSD17B3 | |
| SCHEMBL10749967 | 0.95 | NOS2 (0.62) | NOS2HTTRECQLKDM4EALDH1A1 | |
| SCHEMBL2081805 | 0.89 | NOS2 (0.65) | NOS2RECQLALOX15ALDH1A1FADS1 | |
| SCHEMBL17746129 | 0.84 | ERCC5 (0.53) | HTTALOX15KDM4EALDH1A1HSD17B3 | |
| SCHEMBL7806549 | 0.84 | NOS2 (0.58) | NOS2RECQLALOX15ALDH1A1FADS1 | |
| SCHEMBL27658314 | 0.83 | HTT (0.51) | NOS2HTTALOX15KDM4EALDH1A1 | |
| SCHEMBL13889273 | 0.83 | HTT (0.50) | HTTALOX15KDM4EALDH1A1HSD17B3 | |
| SCHEMBL27712176 | 0.83 | HTT (0.50) | NOS2HTTALDH1A1HSD17B3 | |
| SCHEMBL7082841 | 0.83 | HTT (0.67) | HTTKDM4EALDH1A1HSD17B3 | |
| SCHEMBL2079618 | 0.82 | NOS2 (0.60) | NOS2RECQLALOX15KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5578633-A | VASOPRESSIN AND OXYTOCIN ANTAGONISTS | SANOFI (FR) | 1996-11-26 | — | — | US | disclosed |
| US-5481005-A | N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present | SANOFI (FR) | 1996-01-02 | — | — | US | disclosed |
| US-5397801-A | Affinity for vasopressin and ocytocin receptors; disorders of nervous, cardiovascular and gastrointestinal systems | SANOFI (FR) | 1995-03-14 | — | — | US | disclosed |
| US-5338755-A | Have affinity for vasopressin and ocytocin receptors; intermediates for drugs that act on central nervous system | ELF SANOFI (FR) | 1994-08-16 | — | — | US | disclosed |